All News

2022

May

Media Release / May 12, 2022

Sandoz launches first generic pirfenidone in US for patients with idiopathic pulmonary fibrosis, growing its respiratory portfolio

Read More

April

Media Release / Apr 26, 2022

Novartis delivers solid sales and profit growth. Strong performance of in-market brands supports confidence in mid-term growth outlook

Read More
Media Release / Apr 14, 2022

Sandoz launches generic brimonidine tartrate/timolol maleate eyedrop in US for patients with ocular hypertension, expanding leading ophthalmic portfolio

Read More
Media Release / Apr 06, 2022

Sandoz extends collaboration agreement to drive cutting-edge digital solutions in global fight against antimicrobial resistance (AMR)

Read More

March

Media Release / Mar 14, 2022

Sandoz targets growth opportunities in respiratory and complex generics through acquisition of respiratory device company Coalesce

Read More

February

Media Release / Feb 18, 2022

Sandoz launches generic lenalidomide in 19 countries across Europe, expanding access to essential oncology medicine

Read More
Media Release / Feb 02, 2022

Novartis delivers mid single digit sales growth, margin expansion and advancement of robust pipeline in 2021

Read More
2021

December

Media Release / Dec 22, 2021

Sandoz submits Marketing Authorization Application for proposed biosimilar trastuzumab to EMA

Read More
Media Release / Dec 20, 2021

Sandoz submits Biologics License Application for proposed biosimilar trastuzumab to US FDA

Read More

October

Media Release / Oct 26, 2021

Novartis delivers solid Q3 results, with strong growth in Innovative Medicines. Announces strategic review of Sandoz

Read More